Contribution of ion currents to beat-to-beat variability of action potential duration in canine ventricular myocytes by Szentandrássy, Norbert et al.
ION CHANNELS, RECEPTORS AND TRANSPORTERS
Contribution of ion currents to beat-to-beat variability of action
potential duration in canine ventricular myocytes
Norbert Szentandrássy & Kornél Kistamás & Bence Hegyi & Balázs Horváth &
Ferenc Ruzsnavszky & Krisztina Váczi & János Magyar & Tamás Bányász &
András Varró & Péter P. Nánási
Received: 13 May 2014 /Revised: 11 July 2014 /Accepted: 14 July 2014 /Published online: 2 August 2014
# Springer-Verlag Berlin Heidelberg 2014
Abstract Although beat-to-beat variability (short-term
variability, SV) of action potential duration (APD) is consid-
ered as a predictor of imminent cardiac arrhythmias, the
underlying mechanisms are still not clear. In the present study,
therefore, we aimed to determine the role of the major cardiac
ion currents, APD, stimulation frequency, and changes in the
intracellular Ca2+ concentration ([Ca2+]i) on the magnitude of
SV. Action potentials were recorded from isolated canine
ventricular cardiomyocytes using conventional microelec-
trode techniques. SV was an exponential function of APD,
when APD was modified by current injections. Drug effects
were characterized as relative SV changes by comparing the
drug-induced changes in SV to those in APD according to the
exponential function obtained with current pulses. Relative SV
was increased by dofetilide, HMR 1556, nisoldipine, and
veratridine, while it was reduced by BAYK8644, tetrodotoxin,
lidocaine, and isoproterenol. Relative SVwas also increased by
increasing the stimulation frequency and [Ca2+]i. In summary,
relative SV is decreased by ion currents involved in the nega-
tive feedback regulation of APD (ICa, IKs, and IKr), while it is
increased by INa and Ito. We conclude that drug-induced effects
on SV should be evaluated in relation with the concomitant
changes in APD. Since relative SV was decreased by ion
currents playing critical role in the negative feedback regulation
of APD, blockade of these currents, or the beta-adrenergic
pathway, may carry also some additional proarrhythmic risk
in addition to their well-known antiarrhythmic action.
Keywords Short-term variability . Action potential
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Introduction
Beat-to-beat variability of action potential duration (also
called short-term variability, SV) is an intrinsic property of
various in vivo and in vitro mammalian cardiac preparations
including the human heart [7, 8, 21]. In spite of the fact that
SV is considered one of the best proarrhythmic predictors [1,
11, 22] (but see also Michael et al. [17]), its exact ionic
mechanism is poorly understood. Involvement of many fac-
tors, such as stochastic gating of ion channels [14, 18], cell-to-
cell coupling [27], action potential duration and morphology
[6], stimulation frequency [12], and intracellular calcium
handling [13] in modulation of SV, have been reported;
however, neither their relative contribution nor the role of
the specific cardiac ion currents has been identified in a
well-defined experimental model. Therefore, in absence of
relevant human cellular electrophysiological data, canine
ventricular myocytes were chosen to analyze experimen-
tally the determinants of SV in the present study due to
two reasons. (1) Canine ventricular myocytes are believed
to resemble human ventricular cells regarding their action
potential morphology and kinetics of the underlying ion
currents [19, 20], and (2) a large mass of in vitro and
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in vivo experimental data on beat-to-beat variability have
been obtained in this species [1, 12, 13, 15, 22, 23].
Methods
Isolation of single canine ventricular myocytes
Adult mongrel dogs of either sex were anesthetized with
intramuscular injections of 10 mg/kg ketamine hydrochloride
(Calypsol, Richter Gedeon, Hungary)+1 mg/kg xylazine hy-
drochloride (Sedaxylan, Eurovet Animal Health BV, The
Netherlands) according to protocols approved by the local
ethical committee (license no. 18/2012/DEMÁB) in line with
the ethical standards laid down in the 1964 Declaration of
Helsinki and its later amendments. The hearts were quickly
removed and placed in Tyrode solution. Single myocytes were
obtained by enzymatic dispersion using the segment perfusion
technique, as described previously [2, 3, 9, 16]. Briefly, a
wedge-shaped section of the ventricular wall supplied by the
left anterior descending coronary artery was dissected, cannu-
lated, and perfused with oxygenized Tyrode solution. After
removal of blood, the perfusion was switched to a nominally
Ca2+-free Joklik solution (Minimum Essential Medium Eagle,
Joklik Modification, Sigma) for 5 min. This was followed by
30 min perfusion with Joklik solution supplemented with
1 mg/ml collagenase (Type II. Worthington, Chemical Co.)
and 0.2 % bovine serum albumin (Fraction V., Sigma) con-
taining 50 μM Ca2+. All other drugs were obtained from
Sigma-Aldrich Co. (St. Louis, MO, USA). After gradually
restoring the normal external Ca2+ concentration, the cells
were stored in Minimum Essential Medium Eagle until use.
Recording of action potentials
All electrophysiological measurements were performed at
37 °C. The rod-shaped viable cells showing clear striation
were sedimented in a plexiglass chamber of 1 ml volume
allowing continuous superfusion (at a rate of 2 ml/min) with
modified Krebs solution gassed with a mixture of 95%O2 and
5 % CO2 at pH=7.4. The modified Krebs solution contained
(in mM): NaCl, 128.3; NaHCO3, 21.4; KCl, 4.0; CaCl2, 1.8;
MgCl2, 0.42; and glucose 10. Transmembrane potentials were
recorded using 3 M KCl filled sharp glass microelectrodes
having tip resistance between 20 and 40MΩ. These electrodes
were connected to the input of Multiclamp 700A, 700B or
Axoclamp-2B amplifiers (Molecular Devices, Sunnyvale,
CA, USA). The cells were paced through the recording elec-
trode at steady cycle length of 1 s using 1–2 ms wide rectan-
gular current pulses having amplitudes of twice the diastolic
threshold. Since the cytosol was not dialyzed, time-dependent
changes in action potential morphology were negligible for
the period of our experimental protocol lasting typically not
longer than 25 min, as was demonstrated in Fig. 1e. Action
potentials were digitized (at 200 kHz using Digidata 1322A,
1440A, and 1200 A/D card, purchased from Axon Instru-
ments Inc., Foster City, CA, USA) and stored for later analy-
sis. Series of 50 consecutive action potentials were analyzed to
estimate SVaccording to the following formula:
SV ¼
X
APDnþ 1minus APDnj jð Þ = nbeats  √2
 
where SV is short-term variability, APDn and APDn + 1
indicate the durations of the nth and n + 1th APs, respectively,
at 90 % level of repolarization, and nbeats denotes the number
of consecutive beats analyzed [12]. Changes in SV were
typically presented as Poincaré plots where 50 consecutive
APD values are plotted, each against the duration of the
previous action potential.
Here is to be mentioned that all action potentials analyzed
in the present study were normally driven ones, records taken
in myocytes displaying early or delayed afterdepolarizations
were excluded from evaluation.
Statistics
Results are expressed as mean ± SEM values. Statistical
significance of differences was evaluated using one-way
ANOVA followed by Student's t test. Differences were con-
sidered significant when p was less than 0.05. Each given n
value represents the number of cells/number of animals.
Results
Transmural distribution of SV
Since considerable differences are known to exist in the set and
densities of ion currents, resulting in different action potential
morphologies, in the various layers of the ventricular wall, SV
was compared in myocytes dispersed from the subepicardial
(EPI), subendocardial (ENDO), and midmyocardial (MID)
regions of the left ventricle. SV was the greatest in the MID
cells (2.93±0.07ms), smallest in EPI cells (2.16±0.17ms), and
had an intermediate level in ENDO myocytes (2.53±0.16 ms)
as demonstrated in Fig. 1a–c. Although all these transmural
differences in APD and SV were statistically significant when
analyzed using ANOVA (p<0.05), they were not related to the
spike-and-dome configuration of action potentials observed in
EPI or MID cells. When the transient outward K+ current (Ito)
was suppressed by 1 mM 4-aminopyridine in EPI cells, the
spike-and-dome action potential morphology disappeared but
SV decreased slightly (by 0.57±0.49 ms, N.S., n=9/6) instead
of increasing. This concentration of 4-aminopyridine failed to
modify APD significantly (not shown). As shown in Fig. 1d,
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the observed transmural distribution of SV was largely propor-
tional to APD values. Therefore, the relationship between SV
and APD was further studied.
Relationship between SVand APD
To study the dependence of SVon APD, outward and inward
current injections were applied in current clamp mode. The
current pulses, having amplitudes varied from −600 to +
70 pA, were injected throughout the full duration of the action
potential except phase 0 (Fig. 2a, b). These experiments,
similarly to all results discussed in the followings, were per-
formed in midmyocardial cells. Using current pulses of vari-
ous amplitudes allowed the modification of APD within a
reasonably wide range (from 20 to 500 ms) in a way not
related to exclusive interaction with one or another specific
ion current. The results obtained by analyzing 117 data points
(i.e., corresponding SV and APD values, each representing a
group of 50 consecutive action potentials) are presented in
Fig. 2c–e. As shown in Fig. 2c, the SV-APD relationship
follows exponential kinetics. Similarly, an exponential rela-
tionship was observed when the current-induced changes in
SVand APD were analyzed (Fig. 2d). Furthermore, when the
relative change in SV (defined as ΔSV/ΔAPD) was plotted
against the current-induced change in APD (ΔAPD), this
relationship could also be fitted to an exponential function.
From the ΔSV versus ΔAPD and ΔSV/ΔAPD versus ΔAPD
relations, one can estimate that a change in SV caused
by any given drug or intervention is greater or less than
the value predicted by the concomitant change in APD.
The equations used for the fitting procedure together
with their numerical solutions are presented in Table 1.
The most important conclusion from these experiments is that
any drug-induced change in SV must be evaluated in terms of
relative SV, i.e., by comparing changes in SV to concomitant
changes in APD.
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Fig. 1 Transmural distribution of
beat-to-beat variability (SV) in
canine ventricular myocardium.
Tissue chunks originating from
subepicardial (EPI),
subendocardial (ENDO), and
midmyocardial (MID) layers were
isolated separately; then, SV and
APD were determined for each
cell. a Superimposed sets
containing 50 consecutive action
potentials recorded from EPI,
ENDO, and MID cells,
respectively. b Poincaré plots
constructed using these sets of
action potentials. Individual data
(c) and average values (d)
obtained from EPI (n=13/11),
ENDO (n=18/14), and MID
(n=94/48) myocytes. The
stability of SVand APD as a
function of time is demonstrated
in midmyocardial cells (n=5/4) as
shown in e.Columns and symbols
show arithmetic means, bars
denote SEM values, and asterisks
indicate statistically significant
(p<0.05) differences between
groups determined using
ANOVA
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Effect of the pacing cycle length
Since the duration of a cardiac action potential is strongly
influenced by the frequency of stimulation, it was reasonable
to study whether the frequency-dependent changes in SV are
in line with the predictions of the APD changes. Both APD
and SV increased with lengthening of pacing cycle length
(Fig. 3a–d). When each SV was plotted as a function of the
corresponding APD value, and the exponential curve obtained
from the experiments presented previously in Fig. 2. was
superimposed, the experimental data gave a good fit to the
curve—at least for cycle lengths longer than 0.5 s. SV values
obtained at higher frequencies were larger than predicted by the
APD-SV relationship indicating the possible contribution of
factors other than APD at higher pacing frequencies (Fig. 3e).
Effect of changes in [Ca2+]i on SV
There are various manipulations suitable for modulation of
[Ca2+]i experimentally—the majority of them involves inter-
actions with sarcoplasmic reticular Ca2+ handling. Instead of
these, the simplest strategy was followed in the present
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Fig. 2 Beat-to-beat variability plotted as a function of action potential
duration. a, b Superimposed sets of action potentials recorded from
myocytes exposed to current injections, and the corresponding Poincaré
plots. Although data were obtained using inward and outward current
injections, having amplitudes of −600, −500, −400, −300, −200, −80,
−40, 0, +30, +40, +50, +60, and +70 pA, respectively, only the data
obtained with −80, −40, 0, +30, and +50 pA are presented in the graph. c
SV was plotted against APD for each measurement including the full
scale of current amplitudes. Using the non-injected data (zero current) as
reference, the current-induced changes in SV (ΔSV) were plotted against
the current-induced changes in APD (ΔAPD) in d. Finally, the ΔSV/
ΔAPD ratios were plotted as a function of the corresponding ΔAPD value
(e). Solid curves were generated by fitting data to monoexponential
functions in order to obtain the SV vs APD, ΔSV vs ΔAPD, and ΔSV/
ΔAPD vs ΔAPD relationships (estimated parameters in Table 1). Results
were obtained in nine myocytes of eight dogs by analyzing 117 individual
data points, i.e., corresponding SV and APD values, each representing a
group of 50 consecutive action potentials
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study—based on the assumption that if the cell is loaded
directly with Ca2+, it must increase [Ca2+]i, and conversely,
[Ca2+]i must be reduced by an intracellularly applied Ca
2+
chelator. Exposure of the cells to the Ca2+ ionophore A 23187
(1 μM for 25 min) significantly shortened, while loading the
cells with the cell-permeant acetoxy-methylesther form of the
Ca2+ chelator BAPTA (using 5 μM BAPTA-AM for 25 min)
strongly lengthened APD, although SV was not modified
significantly by these interventions (Fig. 4a–d). However, as
demonstrated in Fig. 4e, A 23187 increased, while BAPTA-
AM decreased the relative SV when it was expressed as a
function of APD change, i.e., as a ΔSV/ΔAPD ratio.
Contribution of the major ion currents to modulation
of beat-to-beat variability: role of K+ currents
The role of the various ion currents in modulation of SV can
be best studied by using their selective activators and
Table 1 Monoexponential fitting of the SV-APD relationship obtained
by varying the amplitude of the injected current
Eq. y0 (ms) A (ms) T (ms) r
2
(1) 0 0.56 131 0.98
(2) −2.39 2.37 97 0.97
(3) 0.008 0.016 129 0.82
Eq. (1) SV=SV0+A×e
APD/T y0=SV0=0
Eq. (2) ΔSV=ΔSV0+A×e
ΔAPD/T y0=ΔSV0
Eq. (3)ΔSV/ΔAPD=(ΔSV/ΔAPD)0+A×e
(ΔSV/ΔAPD)/T y0=(ΔSV/ΔAPD)0
Data were obtained using inward and outward current injections (having
amplitudes of -600, −500, −400, −300, −200, −80, −40, 0, +30, +40, +50,
+60, and +70 pA) during the full duration of the action potential except
phase 0. One hundred seventeen individual data points, obtained from
nine myocytes of eight dogs, were fitted to an exponential function
described by Eq. (1), Eq. (2), or (Eq. 3), as pertinent
APD action potential duration, SV short-term variability, r2 regression
coefficient, y0 minimum value of ordinate
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inhibitors. Contribution of five K+ currents, the rapid delayed
rectifier (IKr), the slow delayed rectifier (IKs), the transient
outward current (Ito), and the inward rectifier (IK1) was studied
using their specific blockers: dofetilide, HMR 1556,
chromanol 293B in the presence of HMR 1556, and BaCl2,
respectively. The ATP-sensitive K+ current (IK-ATP) was acti-
vated by lemakalim (Fig. 5a–e). Plotting the results in the way
as it was done in Fig. 2c–e revealed the specific effects of
these agents on SV both absolutely and relatively (Fig. 5f–h).
Accordingly, the IKr inhibitor dofetilide (10, 30, 100, and
300 nM) increased both APD and SV; however, its effect on
SV was significantly stronger than its effect on APD (relative
enhancement of SV). Similar effect could be observed with
the selective IKs blocker HMR 1556 (0.5 μM), which agent
caused only a small, but statistically significant lengthening of
APD combined with a pronounced increase in SV. This can be
best visualized in Fig. 5h, where the ΔSV/ΔAPD values were
displayed versus ΔAPD. The diamond representing HMR
1556 is located far above the curve in the positive ΔAPD
range. This indicates that the SV-increasing effect of HMR
1556 is much greater than predicted by the earlier discussed
APD-SV relationship—in spite of the fact that IKs is consid-
ered to be a weak current in canine ventricular myocytes under
baseline conditions [24, 26]. A relatively selective Ito blockade
can be achieved by applying chromanol 293B in the presence
of HMR 1556 [25]. Exposure of myocytes to 100 μM
chromanol 293B revealed that suppression of Ito decreased
SV without significant alterations in APD, a result similar to
previously obtained with 1 mM 4-aminopyridine. That is why
the downward triangle, indicating chromanol 293B, is located
also far above the curve (Fig. 5h). Increasing concentrations of
lemakalim (0.1, 0.3, 1, and 5 μM) were used to shorten APD.
Lemakalim decreased both SV and APD, but data points
remained on the curve indicating that this current has little
specific influence on SV. Suppression of IK1 with BaCl2
(gradually increasing BaCl2 concentration from 0.3 to 5 μM)
increased APD and SV, but in this case the SV-increasing
effect was weaker than predicted by the APD-SV relationship,
suggesting that relative SV might be increased by IK1.
However, as it is clearly seen in Fig. 5d, BaCl2 caused
strong triangulation of action potentials, defined as a dif-
ference between the APD90 and APD50 values. Triangula-
tion was 47±3 ms under control conditions, which in-
creased to 90±11 ms in the presence of 5 μM BaCl2
(p<0.05). Assuming that APD measured close to the
plateau level may be more relevant to control action
potential repolarization than APD90 itself, data points ob-
tained with 5 μM BaCl2 should be shifted leftwards on
the horizontal axis in Fig. 5f–h by 43 ms for the sake of
better comparability. Considering these corrections due to
triangulation, each BaCl2 data point touched the exponen-
tial curve (not shown) indicating that IK1 is a current
largely indifferent regarding the modulation of SV.
Contribution of inward currents
The role of Na+ current (INa) was examined by suppression of
INa using TTX and lidocaine, or alternatively, by activation of
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the current by veratridine (Fig. 6a–c). As expected, veratridine
(10, 30, and 100 nM) increased both APD and SV in a
concentration-dependent manner, while both parameters
were simultaneously decreased by tetrodotoxin (TTX,
3 μM) and lidocaine (50 μM). Importantly, the SV-
decreasing effect of INa inhibition, as well as the enhance-
ment of SV caused by veratridine, were larger than pre-
dicted by the APD-SV relationship (Fig. 6f–h), congruently
with an SV increasing action of INa. The other inward
current under investigation was the L-type Ca2+ current
(ICa). It was blocked by 1 μM nisoldipine and enhanced
by 20 or 200 nM of BAY K8644 (Fig. 6d, e). Nisoldipine
increased SV (by 0.52±0.19 ms) while APD was strongly
shortened (by 103±7 ms); both effects were statistically
significant (p<0.05, n=19/13). BAY K8644 increased
APD significantly in 20 nM as well as 200 nM concentra-
tions (APD-lengthening of 38±4 and 82±8 ms was ob-
served in 12/6 and 21/9 myocytes, respectively, p<0.05).
SV was not altered by 20 nM BAY K8644, but it was
increased by 1.96±0.26 ms in the presence of 200 nM
BAY K8644. As demonstrated in Fig. 6f–h, these changes
in SV corresponded to a relative reduction of SV when
compared to the concomitant lengthening of APD. In other
words, SV was strongly diminished by ICa.
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Offsetting the effects of APD changes
The best approach to separate the contribution of a specific
ion current to modulating SV from the effect of the con-
comitant APD change is to apply an electrical or pharma-
cological compensation. The former strategy was used in
the experiments presented in Fig. 7a–f, where the APD-
lengthening effects of 0.1 μM dofetilide, 5 μM BaCl2,
0.1 μM veratridine, and 0.2 μM BAY K8644 were offset
using outward current pulses with constant, properly chosen
amplitude. Similarly, the APD-shortening effects of 3 μM
tetrodotoxin and 1 μM nisoldipine were compensated using
inward current pulses (Fig. 7e, f). After full compensation
for the dofetilide-induced lengthening of APD, a significant
elevation of SV persisted (Fig. 7a), while in the case of
BaCl2 the enhancement of SV was eliminated by restoring
the original value of APD. More specifically, SV, measured
after compensation for the barium-induced lengthening of
APD, fell below the control level of SV (Fig. 7b). How-
ever, applying the argumentation used in the case of
Fig. 5d, based on the barium-induced triangulation of action
potentials, APD50 was overcompensated by the applied out-
ward current. This is in line with our previously discussed
finding, i.e., suggesting that IK1 is really an indifferent current
regarding its possible influence on SV. Similarly to results
obtained with dofetilide, SV remained elevated in the presence
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of veratridine even if APD was fully compensated for
(Fig. 7c)—in contrast to BAY K8644, which resulted in a
subnormal level of SVafter compensation for the APD changes
(Fig. 7d).When INa was blocked by tetrodotoxin, the SV values
were lower than control following compensation of APD
(Fig. 7e), while in the presence of the ICa blocker nisoldipine,
the drug-induced elevation of SV was further increased by
the inward current pulse applied for offsetting the APD
changes (Fig. 7f).
Since one may argue that electrical compensation of APD
changes may shift the membrane potential to one or another
direction, pharmacological compensation was also used in
some experiments (Fig. 7g–j). In this case, the APD-
lengthening effects of dofetilide and veratridine were com-
pensated by lemakalim (using properly chosen concentrations
in each experiment), while the APD-shortening effects of
tetrodotoxin and nisoldipine were compensated by BaCl2.
Although these compensations resulted in full restoration of
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the initial APD90 values, SV remained elevated in the presence
of dofetilide and veratridine, became higher than control in
nisoldipine and lower than control in tetrodotoxin. In summa-
ry, electrical and pharmacological compensation strategies
yielded largely identical results corroborating the specific
SV-lowering effects of IKr and ICa, as well as the SV-
increasing effects of INa. It must be emphasized, however, that
the most dramatic effect was observed with nisoldipine,
independently of the way of compensation, highlighting
the pivotal role of ICa in controlling SV.
Effect of isoproterenol
Summarizing the results above, it could be concluded that two
currents, namely ICa and IKs, were very effective in reducing
the relative SV. If this is true, isoproterenol (ISO) is expected
to decrease SV markedly, since this drug is known to increase
both ICa and IKs simultaneously. ISO (10 nM) caused a small,
although statistically significant shortening in APD at 1 Hz
(reduction of 25±3 ms, p<0.05, n=13/5), which was accompa-
nied with a robust decrease in SV (reduction of 0.89±0.09 ms,
p<0.05, n=13/5), which was much larger than predicted by the
APD-SV relationship (Fig. 8a–c). Indeed, the lowest SV could
be observed at close to normal APD values in the presence of
10 nM ISO. Since ISO is known to increase [Ca2+]i, and
changes in [Ca2+]i were shown to influence relative SV, the
effects of ISO were studied also after the exposure to 5 μM
BAPTA-AM for 25 min. As seen previously, pretreatment
with BAPTA-AM lengthened APD markedly without signif-
icantly affecting SV. In the presence of BAPTA-AM, SV was
decreased and APD was shortened by ISO similarly to results
observed without BAPTA-AM (Fig. 8d, e). The effect of ISO
on relative SVwas largely similar in the presence and absence
of BAPTA-AM, indicating that the effect of ISO on SV was
not related to the concomitant changes in [Ca2+]i, it was rather
caused by the ISO-induced augmentation of ICa and IKs.
Supporting this conclusion, ΔSV/ΔAPD values were identical
in the absence and presence of BAPTA-AM (0.043±0.007
(n=13/5) and 0.045±0.009 (n=7/4), respectively, N.S.).
The effect of 10 nM ISO was studied also at various pacing
cycle lengths. In these experiments, SV was determined by
analyzing 10 consecutive action potentials only in order to
limit the duration of the measurement. Although both the ISO-
induced shortening of APD and reduction of SV increased
with increasing the cycle length of stimulation (Fig. 8f, g),
the relative SV—as demonstrated in Fig. 8h—progressively
decreased at longer cycle lengths.
Discussion
The main goal of the present study was to separate SV
changes related to inhibition of a specific ion current from
those attributable to concomitant changes in APD. This ap-
proach allows for separation of ion currents to APD-
stabilizing, therefore potentially antiarrhythmic currents (ones
decrease relative SV) and to those which increase relative SV.
Members of this latter group cause instability of APD; there-
fore, they can be considered potentially arrhythmogenic.
Using these categories based on predictions of arrhythmia
incidence, three currents could be identified as APD stabilizer:
ICa, IKs, and IKr. INa and Ito were found to increase instability of
APD, while IK1 and IK-ATP appeared to be indifferent. These
results provide an essentially new interpretation of beat-to-
beat variability suggesting that the well-known negative feed-
back regulation of APD may be an important factor of SV
modulation.
Effects of several ion channel modifiers (including
dofetilide [12], HMR 1556 [12], ATX-II [12], and isoproter-
enol [13] in canine, while tetrodotoxin [27] and intracellular
EGTA [27] in guinea pig ventricular cells) on the magnitude
of beat-to-beat variability have been extensively studied; how-
ever, the changes in SV were not correlated by the investiga-
tors with the concomitant APD changes. The first approach to
make such a distinction was the recent study of Heijman et al.
[6], although it was an in silico analysis. Present results,
however, have confirmed many of their predictions: INa and
IKr have great impact on SV, IKr is an APD-stabilizing, while
INa and Ito are APD-unstabilizing currents. IKs was estimated
also as an APD-stabilizing current (having larger impact on
SV than on APD)—in line with our observations, but only our
analysis, based on comparison of ΔSV/ΔAPD changes, was
able to highlight the importance of this interaction in the case
of IKs. The largest difference between our and their results was
found in the role of ICa. Although ICa was considered to be
APD-stabilizing by both studies, it was the most important
modulator in our experiments, as indicated by the results
obtained with nisoldipine and BAY K8644—in contrast to
the moderate effect on SV proposed by the simulation in Fig. 3
of the study of Heijman et al. [6].
According to the conventional interpretation of beat-to-
beat variability, it is due to the stochastic behavior of ion
channel gating [14, 18]. Without questioning the contribution
of this mechanism, here we propose another (probably more
relevant) one to explain the observed changes in SV. Physio-
logical control of APD is based on the following well-known
negative feedback regulation scheme: prolongation of APD
(e.g., due to the enhancement of an inward current) results in
elevation of the plateau, which in turn accelerates the activa-
tion of IKr and IKs leading finally to a shortening of APD.
Accordingly, those currents which are known to be critical
members of this feedback loop—namely ICa, IKr, and IKs—are
expected to decrease the variability of APD, and their inhibi-
tion may have an opposite effect. This interpretation provides
some explanation for the following question: why ICa de-
creases while late INa increases APD. This is not evident since
1440 Pflugers Arch - Eur J Physiol (2015) 467:1431–1443
both currents are inwardly directed, tending to increase APD
together with its variability. The crucial difference between ICa
and late INa is that the former is active mainly during the initial
part of the plateau [2], while the latter is dominant during the
late plateau [10, 28]. As a consequence, ICa has a chance to
shift the early plateau upwards allowing for faster and stronger
activation of IKr and IKs, while in the case of late INa these
changes develop later in time and in a less pronounced way. In
line with this, the SV-increasing effect of late INa is strong
because its activation overlaps the late plateau, where the
membrane resistance is the highest [27]; consequently, a rel-
atively small inward shift in the net membrane current may
result in a large prolongation of APD [3, 4]. This gives also the
physical basis of the exponential relationship between SVand
APD, as was predicted by the simulations of Heijman et al. [6]
and confirmed experimentally by the present work.
In addition to action potential duration, the morphology of
action potential was also suggested to be an important deter-
minant of SV [6]. Heijman et al. simulated square-like action
potential configuration by decreasing both ICa and Ito, while
triangulation was achieved by strongly reducing IK1. SV was
dramatically elevated when it was simulated for a square-like
action potential; on the contrary, triangulation decreased rela-
tive SV. Indeed, characteristic changes in action potential
morphology can be attributed to modifications of many car-
diac ion currents, e.g., suppression of ICa by nisoldipine results
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in plateau depression and square-like morphology. Similarly,
suppression of IK1 caused triangulation of action potentials,
i.e., smaller increase of APD50 than that of APD90. Since the
plateau level is critical in the negative feedback regulation of
APD, its duration is overestimated by APD90 in case of trian-
gulation. This is why IK1 can not be considered as a potentially
proarrhythmic current in dogs in spite of the reduction of
relative SV observed in BaCl2. Although modification of SV
observed in these examples is likely mediated by a change in
action potential morphology, this is not always the case. For
example, exposure of EPI myocytes to 4-aminopyridine con-
verted action potential morphology from EPI to ENDO, but SV
was not increased accordingly. Furthermore, SV was reduced
by ISO very effectively without causing triangulation.
Our results regarding the effects of the stimulation cycle
length on SV is similar to those of Johnson et al. [12], both
studies showing an elevation of SV with increasing the cycle
length. It might be tempting to associate these frequency-
dependent changes in SV with the corresponding changes in
the amplitude of specific ion currents. Since ICa is known to
increase, while IKs is to decrease with increasing the cycle length
of stimulation, the value of this approach seems to be limited.
However, we have shown also that at cycle lengths of 700ms or
longer, the changes in SV was likely due to the concomitant
alterations of APD, since no change in relative SV could be
observed within this frequency range. Specific cycle length-
dependent changes in SV could be observed only at the shortest
cycle lengths, where [Ca2+]i could probably be elevated. Indeed,
manipulation of [Ca2+]i resulted in the expected change in
relative SV, which increased and decreased together with the
changes in [Ca2+]i. In line with this assumption, the ISO-
induced reduction of relative SValso increased with increasing
the cycle length of stimulation. Accordingly, the ISO-induced
reduction of SV was not significant at the shortest cycle length
of 0.3 s, while it became progressively dominant at longer cycle
lengths (including the range between 0.5 and 1 s, corresponding
to the physiological heart rate in humans). It can be speculated
that the ISO-induced reduction of relative SV could partially be
offset by the elevated [Ca2+]i at faster driving rates. It is worth
mentioning that alternans was not observed even at the shortest
cycle length of 300 ms—in contrast to the results of Johnson
et al. [12]. This was likely the consequence of the bicarbonate
content of our Krebs solution, which is known to provide an
excellent intracellular buffering, decreasing thus the probability
of alternans [5]. We have intentionally chosen the simplest way
to manipulate [Ca2+]i, since both chelation of [Ca
2+]i and in-
creasing the calcium entry using a calcium ionophore are ex-
pected to yield steady changes in [Ca2+]i, relatively independent
of the cardiac cycle. This allowed a qualitative prediction of SV
changes associatedwith variation of [Ca2+]i, but is obviously not
suitable for modeling the consequences of dynamic [Ca2+]i
changes occurring when transports between the sarcoplasmic
reticulum and the cytosol are active.
In this investigation, the possible contribution of one or
another ion current to SV was studied by using specific
activators and inhibitors of the ion channel in question. We
tried to apply these agents in relatively selective concentra-
tions (i.e., at concentrations resulting dominantly action on the
targeted ion channel), while in some cases a series of concen-
trations have been applied. Serious problem with drug selec-
tivity arose only in the case of 4-aminopyridine, which is not
selective blocker of Ito—not even at the concentration of
1 mM. Therefore, selective suppression of Ito could be only
achieved by using 100 μM chromanol 293B (of course in the
presence of HMR 1556, since chromanol 293B is also known
to inhibit IKs). Regarding the Ca
2+ ionophore A 23187 and the
Ca2+ chelator BAPTA-AM, the applied concentrations (1 and
5 μM, respectively) were chosen by convention, since the
amount of calcium entry or calcium chelation depends pri-
marily on the time of exposure.
In addition to the better understanding of the mechanism of
beat-to-beat variability, there is one—quite annoying—practical
implication of the present work.We have shown that IKr, IKs, and
ICa act to reduce short-term variability. These are the currents
being generally suppressed by classes 3 and 4 antiarrhythmics,
respectively. Furthermore, 10 nM ISO was the most effective
agent to diminish relative SV out of all drugs tested. Class 2
antiarrhythmics, which are beta-receptor blockers, are expected
to suppress this apparently beneficial adrenergic activity. Al-
though we do not intend to suggest that adrenergic activation
itself would be antiarrhythmic, it must be clearly seen that it has
antiarrhythmic properties as well. Putting together, almost all of
the presently applied antiarrhythmic agents (including the less
side effect carrying beta-blockers) may potentially increase the
beat-to-beat variability of action potential duration limiting this
way their antiarrhythmic potencies.
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